Measurement of Regional Myocardial Blood Flow With N-13 Ammonia and Positron-Emission Tomography in Intact Dogs
N-l3 ammonia mnmcs certain properties of microspheres. It rapidly clears from blood into myocardium where it becomes fixed in proportion to myocardial blood flow. Used with positron emission tomography as a means for quantifying in vivo myocardial indicator concentrations, N-13 ammonia may be useful for noninvasive determination of myocardial blood flow with the arterial reference sampling technique. This possibility was examined in 27 experiments in 10chronically instrumented dogs at control, high and low blood flows. Myocardial blood flow was calculated in vivo from the myocardial N-13 tissue activity concentrations derived from serial cross-sectional images of the heart, the 2 minute arterial input function and the withdrawal rate of arterial blood.
Regional myocardial blood flow can be evaluated both invasively and noninvasively. It is most accurately determined with radioactive microspheres and the arterial reference sampling technique (1,2). The procedure entails administration of radioactive microspheres into the left atrium or ventricle, withdrawal of arterial blood and measurement of regional microsphere tissue concentrations in myocardium by in vitro counting of tissue samples. The latter requirement precludes use of this technique in human beings. However, regional myocardial indicator tissue concentrations can now be measured in vivo with positron emission computed tomography (3) (4) (5) (6) (7) . Moreover, the positron-emitting blood flow tracer, N-13 ammonia, exhibits properties that to some ex-These calculations were compared with blood flow determined by the standard microsphere technique.
Blood flow determined in vivo with N·l3 ammonia and positron emission tomography correlated with microsphere blood flow by Y = -36.2 + I.53x -0.0027x 2 (r = 0.94 with a standard error of the estimate of 16 mllmin per 100 g). For flows from 44 to 200 ml/min per 100 g, the relation between in vivo and in vitro measured myocardial blood flow was nearly linear but reached a plateau at flowshigher than 200 ml/min per 100 g. These results indicate that in dogs, blood flow in the physiologic range can be quantified in vivo with N-13 ammonia and positron emission tomography.
(1 Am Coli CardioI1985; 5:92-100) tent resemble those of radioactive microspheres (8, 9) . N-13 ammonia is extracted and fixed in myocardium in proportion to blood flow. However, its first capillary transit extraction fraction is less than 100% and decreases further with higher flows. The tracer clears rapidly from blood so that the arterial input function is nearly complete within minutes. Unlike radioactive microspheres, N-13 ammonia is administered intravenously, so that use of this tracer in combination with positron emission tomography would allow noninvasive measurements of regional myocardial blood flow in human beings. It was, therefore, the purpose of our study to examine in closed chest dogs the possibility of employing the arterial reference sampling technique with N-13 ammonia and positron emission tomography for measuring regional myocardial blood flow in vivo.
Methods
Animal preparation. Ten mongrel dogs, weighing 20 to 30 kg (mean 25.2), were anesthetized with sodium pentobarbital (25 rug/kg body weight), intubated and ventilated with room air. Catheters were inserted into the carotid artery and through the femoral artery into the abdominal aorta for withdrawing arterial blood and monitoring systemic blood pressure. After a left thoracotomy, an electromagnetic flow probe (series 500, Biotronics) was placed around the proximal left circumflex coronary artery. Mechanical zero flow was established during 10 second coronary occlusions with a snare placed distally to the flow probe. A fine polyethylene cannula was advanced through a puncture wound into the left atrium and used for injection of radioactive microspheres. AH catheters and wires were exteriorized to the posterior aspect of the neck. The thoracic cavity was closed and the chest wall was sutured. The dogs were allowed to recover for 2 to 3 weeks.
Study protocol. The dog was anesthetized (sodium pentobarbital, 25 mg/kg) and carefully positioned in the whole body positron emission transaxial tomograph (ECAT II, Ortec Inc., EG & G) (10) so that the long axis of the left ventricle was perpendicular to the imaging plane. A "rectilinear" transmission scan of the thorax of the dog was used for centering the imaging plane through the mid left ventricle. Transmission images were then recorded for subsequent correction of photon attenuation.
A bolus of 20 mCi of N-13 ammonia contained in 2 to 8 ml of saline solution was injected intravenously while single photon-emitting microspheres were administered into the left atrium. The arterial input function for N-13 ammonia was determined by withdrawing serial 30 second arterial blood samples at a constant rate of 5 ml/min (Harvard Apparatus Co.) over a 6 minute period. For microspheres, the arterial input function was determined by withdrawal of arterial blood from the abdominal aorta at a rate of 4.29 mllmin. Serial positron emission tomographic imaging began at the time of tracer injection and continued until five I minute images were recorded. A total of 27 studies were performed in the 10 dogs. Ten studies were performed in the control period, eight during coronary hyperemia and nine after decreasing blood flow in the circumflex artery territory. A I hour time interval between studies was allowed for physical decay of N-13 activity (9.8 minute half-life). Myocardial blood flow was increased with dipyridamole (Boehringer Ingelheim), infused at a rate of 0.142 mg/min per kg body weight for 4 minutes (II). Regional myocardial blood flow was reduced by constriction of the left circumflex coronary artery with the hydraulic cuff. Changes in circumflex coronary flow were monitored with the electromagnetic flow probe. Tracer injection, blood sampling and serial tomographic imaging were begun in the hyperemic experiments 4 minutes after the end of the dipridamole infusion, and in the partial occlusion experiments as soon as circumflex coronary artery blood flow had stabilized at a lower level. The dog was maintained in the same position during all experiments. This was accomplished by drawing a line on the dog's chest along the projection of the lower power neon laser beam of the tomograph and keeping the laser beam aligned with the demarcation line throughout the experiment.
After completion of the imaging studies, 10 em long needles were pushed along the demarcation line through the chest wall in the direction of the imaging plane into the thorax and myocardium to identify the anatomic crosssection of the heart that had been imaged by positron emission tomography. The dog was then killed with concentrated potassium chloride solution, the chest cavity opened and the heart removed. A I em thick cross-sectional slice of the left ventricle along the needle insertion sites (that is, corresponding to the imaged cross section) was obtained and photographed, and the wall thickness determined at six equally spaced sites. The left ventricular cross section was then divided into approximately I g samples. Each tissue sample was weighed and transferred into counting tubes, and the tissue microsphere activity concentrations determined by well counting.
Measurement of regional myocardial blood flow with radioactive microspheres. Regional myocardial blood flow at the time of each N-13 ammonia injection was determined with the microsphere technique (I). Carbonized polystyrene microspheres (15 ± 5 /-L in diameter, suspended in 10% dextran with I drop of Tween 80; 3M Company) were resuspended with a vortex shaker and then by ultrasonification. Approximately 2 x 10 6 microspheres labeled with cobalt-57, tin-113, niobium-95, scandium-46 or ruthenium-103 were injected. The activity in the blood and myocardial tissue samples was measured in a sodium iodide (thallium) well counter.
Regional myocardial bloodjlow (RMBF) was calculated using equation I:
Fa' c, RMBF = ----C;;-. 100 (ml/min per 100 g), (1) where Fa is the withdrawal rate of arterial blood (ml/rnin), C m is the activity in the myocardial tissue sample (counts/min per g) and C, is the total activity in the arterial blood sample (counts/min) .
Positron emission tomographic imaging, data analysis and calculation of blood flow with N-13 ammonia. N-13 ammonia was produced at the University of California at Los Angeles Medical Cyclotron as described previously (8, 9) . Serial positron tomographic imaging in the ungated, fixed time mode was begun at the time of tracer injection and continued until five serial I minute images were recorded. The spatial resolution was 17 mm at full width-half maximum with a slice thickness of 19 mm. Because of a 20 second interval between the acquisition of each image, the total imaging time amounted to 6.3 minutes. To evaluate possible changes in tissue N-13 ammonia concentrations over time, additional images were obtained in five studies 20 minutes after tracer injection.
Six regions of interest were assigned to the left ventricular myocardium in each image. Their location corresponded to those on the anatomic cross sections where re-gional wall thickness was determined. Each region of interest was 0.84 crrr' in area (21 pixels). The counts per pixel were then determined, averaged for the entire region of interest and expressed as mean counts/pixel per min. Regional myocardial blood flow was calculated by the arterial reference sampling technique using equation 1. N-13 ammonia activity was measured by well counting.
The activity of the myocardial tissue sample (em) was determined from the cross-sectional positron emission tomographic images from myocardial regions of interest as described earlier (7, 12,13) using equation 2:
Positron emission tomographic imaging and blood flow measurements. Positron emission tomography yielded good quality images of the myocardial distribution of N-13 ammonia. Examples of serial images recorded at control, during coronary hyperemia and during circumflex coronary artery constriction are shown in Figure I . The changes in myocardial and blood N-13 activity concentrations after intravenous administration of N-13 ammonia in a control experiment are shown in Figure 2 . N-13 activity in the blood is highest in the third sample (withdrawn 30 to 60 seconds after injection). It rapidly declines thereafter and remains relatively constant after 2.5 minutes.
Myocardial N-13 activity concentrations increase most early after tracer injection and then stabilize ( Table 1) . These changes were similar for all experiments and are summarized for all studies in Figure 3 . These timedependent N-13 activity concentrations were similar for the control, hyperemic and partial occlusion experiments. Myocardial N-13 activity concentrations increased most dramatically (by 13 to 29%) from the first (at 0.5 minute) to the second measurement (at 1.83 minutes). For the next 4 minutes, myocardial N-13 activity concentrations increased less rapidly. Interimage changes in myocardial N-13 activity concentrations were only small. In five studies with additional images at 20 minutes after N-13 ammonia administration, regional N-13 activity concentrations were only 13 to 15% higher than those at 6.3 minutes. 
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Results
Hemodynamic findings, In the 10 control experiments, myocardial blood flow measured by microspheres averaged 99 ± 41 ml/min per 100 g. Mean arterial blood pressure was 110 ± 18 mrnHg and heartrate was 108 ± 24 beats/min. In the eight hyperemic experiments, myocardial blood flow increased to 169 ± 66 mllmin per 100 g, while arterial blood pressure averaged 90 ± 20 mm Hg and heart rate was 142 ± 20 beats/min. In the nine partial coronary occlusion experiments, blood flow in the underperfused segment averaged 58 ± 28 mllmin per 100 g, while mean arterial pressure and heart rate averaged 106 ± 16 mm Hg and 1\8 ± 28 beats/min, respectively.
In arterial blood, N-13 activity concentrations rapidly increased after tracer administration, reached a maximum in the second blood sample and then declined (Fig. 2) . Beginning with the fourth blood sample (90 to 120 seconds Figure 2 . Myocardial N-13 tissue concentrations determined from serial positron emission tomographic images (A) and the arterial blood N-13 ammonia concentrations derived from serial 30 second arterial blood samples (B) in a control experiment. In A, the width of each bar represents the acquisition time of each serial image and its height represents the N-13 activity concentration. In B, the width of each bar corresponds to the 30 second blood sampling time and its height to the N-13 activity concentration. Note the increase in N-13 activity tissue concentrations as well as thehigher blood activity concentrations in the first three samples. After 2 minutes, the activity remains relatively constant with most of the N-13 activity bound to amino acids.~3~4 after tracer injection), N-13 activity concentrations remained low and without further significant changes over the next 4 minutes. Accordingly, the arterial input function was nearly complete at the time of the second scan, that is, at 1.83 minutes after tracer injection. Myocardial blood flow was, therefore, calculated from the myocardial N-13 activity tissue concentrations derived from the second of the serial tomographic images and the integral of the arterial N-13 concentrations to that time.
In vivo calculated regional myocardial blood flows in a partial occlusion experiment are compared in Figure 4 with regional myocardial blood flows by the in vitro microsphere technique. Both measurements agree well, although the in vivo method yields lower values than the in vitro microsphere technique.
The two blood flow measurement techniques are comparedfor all dog experiments after averaging the tissue N-13 concentrations in all six regions of interest in individual experiments for the control and hyperemic studies. In the partial occlusion experiments, the tissue concentrations measured in vitro and in vivo in the low flow segment were averaged. This usually involved two to three regions of interest on the cross-sectional images and the corresponding two to three tissue samples removed from the myocardial slices. Figure 5 Blood flows were also calculated from the myocardial N-13 activity concentrations at 3.17,4.50 and 5.83 minutes after tracer injection and the arterial input function integrated only to 2.0 minutes. The rationale for the latter approach was that the arterial input function was nearly complete and residual activity in the blood represented primarily N-13-labeled amino acids. Blood flows calculated by the first approach decreased progressively and significantly with time ( Table 2 , Fig. 4 ). Flows calculated from the 5.83 minutes scan and the arterial input function to that time were 24.3 ± 8% lower than those calculated at 1.83 minutes after tracer injection. Conversely, flows calculated from the same scan but using the integral of the arterial input function to 2.0 minutes were 13.3 ± 6.5% higherthan those calculated at 1.83 minutes. Comparisons by Student's t test for paired data disclosed the moderate changes in calculated flows to be statistically significant from 1.83 to 4.5 minutes but not from 4.5 to 5.83 minutes. The table lists the average percent changes in blood flow calculated from scan 2 and the integral of arterial N-I3 activity concentrations to that time. Statistically significant differences between interscan changes are indicated by * = P < 0.05 and t = p < 0.001. NS = not significant. therefore, the distribution of myocardial blood flow at the time of the injection (9). Finally, N-13 ammonia clears rapidly from the blood. After intravenous injection, N-13 activity in blood declines within 2 minutes to approximately 5% of its peak value and in 5 minutes to about I to 2% (8, 21) . Consequently, tracer recirculation and its effects on tracer tissue concentrations should be small after the initial 2 minutes after tracer injection. The residual blood activity thereafter represents N-13 bound primarily to amino acids rather than N-13 ammonia (22) . Their extraction by dog myocardium is low (23, 24) .
Regional Relation between myocardial blood flow and N-B ammonia tissue concentration. The rationale for use of N-13 ammonia for determining in vivo regional myocardial blood flow is based on the properties of this tracer which, to some extent, resemble those of radioactive microspheres. Myocardium accumulates and retains the tracer in proportion to blood flow. However, the extraction fraction is less than 100% and declines with higher flows. Accordingly, the overall relation between blood flow and myocardial N-13 ammonia tissue concentration is nonlinear. N-13 ammonia becomes metabolically fixed in myocardium (9, (18) (19) (20) , yet the trapping mechanism appears to be relatively insensitive to changes in the hemodynamic and metabolic state of the heart (9). Clearance of N-13 activity from myocardium is slow. At the time of positron emission tomographic imaging, the tracer distribution in myocardium reflects, Figure 5 .
MYOCAIIDIAL BLOOD FLOW 300 in this experiment cannot account for the leveling off of measured values at high flow rates. In the hyperemic experiments, dipyridamole lowered peripheral resistance with a compensatory increase in heart rate. Higher heart rates result in an increase in mean myocardial wall thickness and, hence, improve rather than worsen the retrieval of myocardial activity from the cross-sectional images. The stabilizing of in vivo measurements at higher levels is, as is the case for most diffusible indicators, a function of the flow-dependent decrease in the extraction fraction.
In vitro versus in vivo calculatedjiows. Using the regression equation describing the relation between in vitro and in vivo calculated flows, the in vivo calculated flows can be corrected. For example, applying this correction to our data, in vivo calculated data correlated linearly with the in vitro microsphere measurements (Fig. 7) . The slope of the regression line approaches unity, indicating that the correction yields values that are comparable with those calculated by the in vitro technique. Although encouraging, there remains considerable scatter of the data points about the regressionline, with an average standard error of 24 mllmin per 100 g. Moreover, the validity of this correction requires further validation in a prospective manner.
The observed data scatter may be attributed to several factors. Flow determined with particulate tracers such as microspheres is known to differ from flow measured with diffusible indicators (25) . Also, the cross-sectional images were recorded in an ungated mode. Wisenberg et al. (7), demonstrated previously that indicator tissue concentrations are determined more accurately from electrocardiographic gated ratherthan from ungated images. Because of the longer acquisition times required for gated image acquisition, the use of gated image acquisition in this study was limited by the time of the first scan. It increased by about 18% from the first to the second scan, while subsequent increaseswere only small and ranged from 2.3 to 7.3% between scans acquired over the next 4 minutes. These increases were similar in the hyperemic, control and low flow experiments. The step-up in tissue concentrations from the first to the second image with only minor subsequent increases implies that the arterial input function for N-13 ammonia was nearly complete at the time of the second image acquired 1.83 minutes after tracer injection. Methodologic considerations. In vivo measurements of myocardial blood flow systematically underestimated blood flow determined by the microsphere technique. This is because N-13 ammonia is extracted less than 100% during a single capillary transit. Over the flow range from 40 to about 200 ml/min per 100 g, this relation is almost linear as indicated by the linear regression equation for flows ranging from 44 to 180 ml/min per 100 g of y = -7.4 + 0.94x, a correlation coefficient of 0.92 and a standard error of the estimate of 16 mllmin per 100 g. At higher blood flows, the relation stabilizes. This plateau is most likely the result of a declining "extraction fraction" for N-13 ammonia rather than an artifactual decrease in count recovery. Altered wall motion can cause artifactual changes in count recovery, but the relatively short physical half-life of N-13 ammonia. Last, because of variations in the arterial input function, the cut-off time at 2 minutes may not always accurately reflect the true arterial input function and introduces additional errors.
Low spatial resolution of the imaging device used in this study. This is another potential source of error. It results in substantial loss in recovered counts (approximately 30 to 50%) as a consequence of the partial volume effect. Accordingly, the factor required for correction of regional wall thickness is large and likely to affect the accuracy of the measurements. Discrepancies between average wall thickness of the live beating heart and the wall thickness measured postmortem further reduce the accuracy. Inconsistencies between the sites of in vivo tissue concentration and of postmortem wall thickness measurements may further contribute to the data scatter. These factors seem largely responsible for variations in segmental tracer concentrations between the various regions of interest along myocardial cross-sectional images that averaged 9 ± 3% in the control experiments. These variations prompted us to use the average instead of the regional flow values. Nevertheless, regional measurements of blood flow are possible as indicated in Figure 4 . Many of these limitations can be overcome with newer, high temporal and spatial resolution tomographs that will reduce the magnitude of correction factors for partial volume effect, permit measurements of segmental wall thickness directly from the images and allow electrocardiographic synchronized image acquisition.
Effects of time on measurements of blood flow. In vivo measurements of blood flow with N-13 ammonia and positron emission tomography are affected by the time of measurement after tracer injection. Calculation of blood flow from later scans (3.17 to 5.83 minutes) and the integral of the arterial concentration to the time of image acquisition yielded progressively lower values. Calculated flows at 5.83 minutes were 24.3 ± 8.0% lower than those calculated from the second scan. Use of the arterial input function to only 2 minutes for deriving blood flow from consecutive scans reduced the magnitude of time-dependent changes. For example, the calculated values from the third, fourth and fifth scan, respectively, were only 6.7,10.6 and 13.3% higher than those calculated from the 2 minute scans. Thus, the latter approach reduces the effect of time dependency on calculated flows.
Possible solutions to minimize the effects ()( time on calculated blood flow are correction of values for the time between tracer injection and imaging. For example, blood flows calculated from the fifth scan could be corrected for the 13.3% overestimation. This will be important when myocardial blood flow is determined with this approach with a single slice tomograph and the entire heart imaged by recording serially contiguous cross-sectional images. With the multislice capability of newer tornographs, several cross sections could be acquired simultaneously, which would obviate the need for serial imaging.
Clinical applications. In comparison with other more complex techniques currently developed for measuring myocardial blood flow like the rubidium-82 technique (26, 27) or the oxygen-IS water technique (28, 29) , the simplicity of the current approach offers several advantages. The technique requires only one measurement of the myocardial N-13 tissue concentration between 2 and 6 minutes after intravenous tracer injection, withdrawal of arterial blood for 2 minutes, well counter measurements of the arterial input function and calibration of the positron emission tomograph with the well counter.
Given the near linear relation between in vivo and in vitro measurements within the low to moderately high flow range, the N-13 ammonia/positron emission tomographic technique will be sensitive for blood flow determinations in patients at rest or during moderate hyperemia as well as in patients with regional perfusion abnormalities. The utility of this technique at higher flow ranges will largely depend on the accuracy of regional tissue concentration measurements with positron emission tomography. The shortcomings with current instrumentation, as outlined earlier, represent a major limitation for the use of this approach to the human heart in which in vivo determination of ventricular wall thickness in exactly the imaged cross section may be limited or impossible. The newer generation positron emission tomographs, however, offer far better temporal and spatial resolutions so that rapid serial electrocardiographic gated cross-sectional imaging will be possible and the loss in count recovery considerably less. For correction of residual count recovery, direct measurements of regional wall thickness may be possible directly from the cross-sectional images. Finally, it may be possible to determine the arterial input function directly from regions of interest assigned to the left ventricular blood pool, thus obviating the need for arterial blood sampling and rendering this approach largely noninvasive.
The potential of N-13 ammonia for external quantification of regional blood flow in human subjects has been indicated in earlier studies (16) . Application of this technique in human beings will require rigorous testing. The optimal time for imaging and, hence. determination of segmental tracer tissue concentrations will depend on the time when the tracer has cleared almost completely from blood and when the arterial input function as well as myocardial tracer tissue uptake are completed. The possibility of using positron emitting microspheres for measuring regional blood flow with the arterial reference sampling technique and positron emission tomography (Selwyn et al., unpublished data) would further allow validation of the N-13 ammonia technique against the microsphere technique as the standard.
